Pfizer to establish 190 million euro biologics plant in Cork
Pfizer has announced plans to invest 190 million euros to set up a new biologics facility in Ireland, which will create 100 “high quality” jobs over three years.
Read MoreAuthor: Kevin Grogan
UK court ruling puts NICE in dock over Alzheimer’s guidance
Drugmakers and patient groups in the UK are celebrating after the country’s Court of Appeal ruled that the National Institute for Health and Clinical Excellence (NICE) has “breached the principle of procedural fairness” in making its current guidance which in effect bans the use of anti-dementia medicines for patients with mild Alzheimer’s disease.
Read MoreSepracor acquires Oryx as sales beat analyst expectations
Sepracor has posted a better-than-expected set of financials for the first-quarter profit despite a decline in sales for its top two products, the sleep drug Lunesta and the asthma treatment Xopenex.
Read MoreGSK CEO puts focus on emerging markets for future growth
Less than a month until he takes over as chief executive at GlaxoSmithKline, Andrew Witty has announced a number of changes to help the firm face “a rapidly changing environment”.
Read MoreBoehringer gets full EU OK for Aptivus while Vargatef impresses
European regulators have granted full approval to Boehringer Ingelheim’s HIV drug Aptivus, which had previously only been allowed to market it under exceptional circumstances.
Read More
